Correlation between hepatic tumor blood flow and glucose utilization in a rabbit liver tumor model

Radiology

Volumn 239, Issue 3, 2006, Pages 740-750

  Stewart, Errol E ^a,b,c   Chen, Xaiogang ^c   Hadway, Jennifer ^a,c   Lee, Ting Yim ^a,b,c  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFACT REDUCTION; BREATH HOLDING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FUNCTIONAL COMPUTED TOMOGRAPHY; GLUCOSE UTILIZATION; IN VIVO STUDY; ISOTOPE LABELING; LINEAR REGRESSION ANALYSIS; LIVER BLOOD FLOW; LIVER FUNCTION; LIVER TUMOR; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STANDARDIZED UPTAKE VALUE; TUMOR GROWTH;

ANIMALS; AORTA; BLOOD VOLUME; CAPILLARY PERMEABILITY; CARCINOMA; CELL LINE, TUMOR; CINERADIOGRAPHY; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEPATIC ARTERY; IMAGE PROCESSING, COMPUTER-ASSISTED; LIVER; LIVER NEOPLASMS; MALE; PORTAL VEIN; POSITRON-EMISSION TOMOGRAPHY; RABBITS; RADIOPHARMACEUTICALS; REGIONAL BLOOD FLOW; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33744780453     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2393041382     Document Type: Article

References (43)

1. Johnson PC. Autoregulation of blood flow. Circ Res 1986;59:483-495.
2. Jones RD, Berne RM. Evidence for a metabolic mechanism in autoregulation of blood flow in skeletal muscle. Circ Res 1965;17:540-554.
3. Lehtio K, Oikonen V, Gronroos T, et al. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET. J Nucl Med 2001;42:1643-1652.
4. Mankoff DA, Dunnwald LK, Gralow JR, et al. Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy. J Nucl Med 2002;43:500-309.
5. McFalls EO, Murad B, Haspel HC, Marx D, Sikora J, Ward HB. Myocardial glucose uptake after dobutamine stress in chronic hibernating swine myocardium. J Nucl Cardiol 2003;10:385-394.
6. Sokoloff L. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Fed Proc 1981;40:2311-2316.
7. Kallinowski F, Schlenger KH, Kloes M, Stohrer M, Vaupel P. Tumor blood flow: the principal modulator of oxidative and glycolytic metabolism, and of the metabolic micromilieu of human tumor xenografts in vivo. Int. J Cancer 1989;44:266-272.
8. Brown RS, Fisher SJ, Wahl RL. Autoradiographic evaluation of the intra-tumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xeuografts of human ovarian adenocarcinoraa. J Nucl Med 1993;34:75-82.
9. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J Nucl Med 1994;35:1067-1073.
10. Teicher BA. Hypoxia and drug resistance. Cancer Metastasis Rev 1994;13:139-168.
11. Lee TY. Functional CT: physiological models. Trends Biotechnol 2002;20(12 suppl): S3-S10.
12. Brix G, Ziegler SI, Bellemann ME, et al. Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply. J Nucl Med 2001;42:1265-1273.
13. Graham MM, Peterson LM, Hayward RM. Comparison of simplified quantitative analyses of FDG uptake. Nucl Med Biol 2000;27:647-655.
14. Ackerman NB. The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974;75:589-596.
15. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993;188:405-411.
16. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y. Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 2001;176:667-673.
17. Richardson PD, Withrington PG. Liver blood flow. I. Intrinsic and nervous control of liver blood flow, Gastroenterology 1981;81:159-173.
18. Schenk WG Jr, McDonald JC, McDonald K, Drapanas T. Direct measurement of hepatic blood flow in surgical patients: with related observations on Hepatic flow dynamics in experimental animals. Ann Surg 1962;156:463-471.
19. Hamacher K, Coenen HH. Efficient routine production of the 18F-labelled amino acid O-2-18F fluoroethyl-L-tyrosine. Appl Radiat Isot 2002;57:853-856.
20. Johnson JA, Wilson TA. A model for capillary exchange. Am J Physiol 1966;210:1299-1303.
21. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain. I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365-1377.
22. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6:731-744.
23. Crone C. The permeability of capillaries in various organs as determined by use of the 'indicator diffusion' method. Acta Physiol Scand 1963;58:292-305.
24. Joseph PM, Ruth C. A method for simultaneous correction of spectrum hardening artifacts in CT images containing both bone and iodine. Med Phys 1997;24:1629-1634.
25. Cenic A, Nabavi DG, Craen RA, Gelb AW, Lee TY. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999;20:63-73.
26. Materne R, Van Beers BE, Smith AM, et al. Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 2000;99:517-525.
27. Fukumura D, Yuan F, Monsky WL, Chen Y, Jain RK. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 1997;151:679-688.
28. Folkman J. Tumor angiogenesis. In: Loitta LA, Mendelsolin J, Israel MA, eds. The molecular basis of cancer. Philadelphia, Pa: Saunders, 1995; 206-232.
29. Manz R, Otte J, Thews G, Vaupel P. Relationship between size and oxygenation status of malignant tumors. Adv Exp Med Biol 1983;159:391-398.
30. Claffey KP, Brown LF, del Aguila LF, et al. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996;56:172-181.
31. Weber G. Enzymology of cancer cells. II. N Engl J Med 1977;296:341-551.
32. Weber G. Enzymology of cancer cells. I. N Engl J Med 1977;296:486-492.
33. Monakhov NK, Neistadt EL, Shavlovskil MM, Shvartsman AL, Neifakh SA. Physicochemical properties and isoenzyme composition of hexokinase from normal and malignant human tissues. J Natl Cancer Inst 1978;61:27-34.
34. Ward-Hartley KA, Jain RK. Effect of glucose and galactose on microcirculatory flow in normal and neoplastic tissues in rabbits. Cancer Res 1987;47:371-377.
35. DiPette DJ, Ward-Hartley KA, Jain RK. Effect of glucose on systemic hemodynamics and blood flow rate in normal and tumor tissues in rats. Cancer Res 1986;46:6299-6304.
36. Vaupel P, Thews G. Pathophysiological aspects of glucose uptake by the tumor tissue under various conditions of oxygen and glucose supply. Adv Exp Med Biol 1976;73:547-553.
37. Fukuda K, Taniguchi H, Koh T, Kunishima S, Yamagishi H. Relationships between oxygen and glucose metabolism in human liver tumours: positron emission tomography using 150 and 18F-deoxyglucose. Nucl Med Commun 2004;25:577-583.
38. Zasadny KR, Tatsumi M, Wahl RL. FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers. Eur J Nucl Med Mol Imaging 2003;30:274-280.
39. Iwata Y, Shiomi S, Sasaki N, et al. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med 2000;14:121-126.
40. Cremerius U, Bares R, Weis J, et al. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET. J Nucl Med 1997;38:26-30.
41. Ziegler SI, Haberkorn U, Byrne H, et al. Measurement of liver blood flow using oxygen-15 labeled water and dynamic positron emission tomography: limitations of model description. Eur J Nucl Med 1996;23:169-177.
42. Raleigh JA, Dewhirst MW, Thrall DE. Measuring tumor hypoxia. Semin Radiat Oncol 1996;6:37-45.
43. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.